HIV Detail
News and Resources
Related Products
Advancing Antiviral Therapy
Our Capabilities
Pharsight is the largest drug development modeling and simulation company in the world. Having engaged on nearly 350 projects in the past five years, Pharsight Strategic Consulting Services provides expert scientific capabilities to address critical development questions from preclinical testing to post-launch market surveillance. Pharsight resources include seasoned practitioners from industry, government, academia, and consulting. Our multidisciplinary team of more than 20 Ph.D. and MD scientists can optimize your drug development decisions through quantitative exploration of development knowledge and uncertainty that integrates drug/disease models, trial models, and predictive market models.
Leaders in HIV and HCV Drug Development Guidance
Pharsight has conducted more than 25 HIV and HCV projects over the past decade, in all phases and covering critical issues in trial design, dose selection, and development strategy. Our recent experience covers most mechanisms of action including protease inhibitors, NNRTIs, NRTIs, and two novel mechanisms. In addition, Pharsight has taken a leadership role at over a dozen industry conferences, has published in peer reviewed journals, and has other publications and collaborations in progress.